I'm curious what makes you curious. Is it more of a concern with fusion proteins like this, or perhaps the high rate of infusion reaction?
I just assumed there were no objective responses by virtue of omission, but you're right the abstract was not explicit on this point. It's not like they stated best response so far was SD and truth is we don't know about the other 4 pts still on drug
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.